View Item 

Show simple item record

Co‐ingestion of prescription drugs and alcohol in US adults aged 50 years or older

dc.contributor.authorSchepis, Ty S.
dc.contributor.authorFord, Jason A.
dc.contributor.authorMcCabe, Sean Esteban
dc.date.accessioned2021-12-02T02:31:45Z
dc.date.available2022-12-01 21:31:44en
dc.date.available2021-12-02T02:31:45Z
dc.date.issued2021-11
dc.identifier.citationSchepis, Ty S.; Ford, Jason A.; McCabe, Sean Esteban (2021). "Co‐ingestion of prescription drugs and alcohol in US adults aged 50 years or older." Human Psychopharmacology: Clinical and Experimental 36(6): n/a-n/a.
dc.identifier.issn0885-6222
dc.identifier.issn1099-1077
dc.identifier.urihttps://hdl.handle.net/2027.42/171039
dc.description.abstractObjectiveTo examine prevalence of past‐month prescription drug misuse (PDM) and alcohol co‐ingestion and its correlates in adults age 50 or older.MethodsData were from the 2015–2018 US National Survey on Drug Use and Health (n = 35,190). PDM‐alcohol co‐ingestion was defined as prescription opioid, tranquilizer/sedative, or stimulant misuse while “drinking alcohol or within a couple of hours of drinking.” Co‐ingestion prevalence was estimated, and logistic and negative binomial regressions examined the sociodemographic, physical health, mental health, substance use, and substance use disorder (SUD) correlates of co‐ingestion.ResultsOver 344,000 adults aged 50 years or older (0.3%) engaged in past‐month PDM‐alcohol co‐ingestion, or 27.4% of those with past‐month PDM. Past‐month co‐ingestion was linked to greater past‐month alcohol use frequency and elevated adjusted odds ratios (aORs) for all examined substance use outcomes (e.g., non‐PDM SUD aOR = 21.8; 49.7% prevalence rate). The aOR for suicidal ideation was 506% higher in those with co‐ingestion than those without past‐year PDM.ConclusionsUS adults aged 50 years or older with past‐month PDM‐alcohol co‐ingestion are at high risk for SUD and concerning mental health symptoms. Screening for mental health and substance use treatment is warranted among aging adults with signs of PDM, especially involving co‐ingestion.
dc.publisherWiley Periodicals, Inc.
dc.publisherAmerican Psychiatric Association
dc.subject.otherolder adults
dc.subject.otherprescription opioid
dc.subject.otherstimulant
dc.subject.othertranquilizer
dc.subject.otheralcohol
dc.titleCo‐ingestion of prescription drugs and alcohol in US adults aged 50 years or older
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelPsychiatry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/171039/1/hup2803.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/171039/2/hup2803_am.pdf
dc.identifier.doi10.1002/hup.2803
dc.identifier.sourceHuman Psychopharmacology: Clinical and Experimental
dc.identifier.citedreferenceOsborne, V., Striley, C. W., Nixon, S. J., Winterstein, A. G., & Cottler, L. B. ( 2019 ). Sex differences in patterns of prescription opioid non‐medical use among 10‐18 year olds in the US. Addictive Behaviors, 89, 163 – 171. https://doi.org/10.1016/j.addbeh.2018.10.009
dc.identifier.citedreferenceMcCabe, S. E., West, B. T., Teter, C. J., & Boyd, C. J. ( 2012 ). Co‐ingestion of prescription opioids and other drugs among high school seniors: Results from a national study. Drug and Alcohol Dependence, 126 ( 1–2 ), 65 – 70. https://doi.org/10.1016/j.drugalcdep.2012.04.017
dc.identifier.citedreferenceMcNeely, J., Wu, L. T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Schwartz, R. P., Russell, L., Nordeck, C., Sharma, A., O’Grady, K. E., Bouk, L. B., Cushing, C., King, J., Wahle, A., & Schwartz, R. P. ( 2016 ). Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients. Annals of Internal Medicine, 165 ( 10 ), 690 – 699. https://doi.org/10.7326/m16‐0317
dc.identifier.citedreferenceMowbray, O., & Quinn, A. ( 2015 ). Prescription pain reliever misuse prevalence, correlates, and origin of possession throughout the life course. Addictive Behaviors, 50, 22 – 27. https://doi.org/10.1016/j.addbeh.2015.06.006
dc.identifier.citedreferenceNational Institute of Alcohol Abuse and Alcoholism. ( 2004 ). NIAAA newsletter, Winter 2004. Office of Research Translation and Communications, NIAAA.
dc.identifier.citedreferenceNational Institute on Drug Abuse. ( 2019 ). Overdose death rates. https://www.drugabuse.gov/related‐topics/trends‐statistics/overdose‐death‐rates
dc.identifier.citedreferenceO’Malley, P. M., Bachman, J. G., & Johnston, L. D. ( 1983 ). Reliability and consistency in self‐reports of drug use. International Journal of the Addictions, 18, 805 – 824.
dc.identifier.citedreferencePalamar, J. J., Han, B. H., & Martins, S. S. ( 2019 ). Shifting characteristics of nonmedical prescription tranquilizer users in the United States, 2005‐2014. Drug and Alcohol Dependence, 195, 1 – 5. https://doi.org/10.1016/j.drugalcdep.2018.11.015
dc.identifier.citedreferenceReinert, D. F., & Allen, J. P. ( 2002 ). The alcohol use disorders identification test (AUDIT): A review of recent research. Alcoholism: Clinical and Experimental Research, 26 ( 2 ), 272 – 279.
dc.identifier.citedreferenceSchepis, T. S., Acheson, S., Zapp, D., & Swartzwelder, H. S. ( 2019 ). Alcohol use and consequences in matriculating US college students by prescription stimulant/opioid nonmedical misuse status. Addictive Behaviors, 98, 106026. https://doi.org/10.1016/j.addbeh.2019.06.015
dc.identifier.citedreferenceSchepis, T. S., De Nadai, A. S., Ford, J. A., & McCabe, S. E. ( 2020 ). Prescription opioid misuse motive latent classes: Outcomes from a nationally representative US sample. Epidemiology and Psychiatric Sciences, 29, e97. https://doi.org/10.1017/s2045796020000037
dc.identifier.citedreferenceSchepis, T. S., & McCabe, S. E. ( 2016 ). Trends in older adult nonmedical prescription drug use prevalence: Results from the 2002‐2003 and 2012‐2013 National Survey on Drug Use and Health. Addictive Behaviors, 60, 219 – 222. https://doi.org/10.1016/j.addbeh.2016.04.020
dc.identifier.citedreferenceSchepis, T. S., & McCabe, S. E. ( 2019 ). Prescription tranquilizer/sedative sources for misuse in older adults. Substance Use & Misuse, 54 ( 11 ), 1908 – 1912. https://doi.org/10.1080/10826084.2019.1613434
dc.identifier.citedreferenceSchepis, T. S., Teter, C. J., Simoni‐Wastila, L., & McCabe, S. E. ( 2018 ). Prescription tranquilizer/sedative misuse prevalence and correlates across age cohorts in the US. Addictive Behaviors, 87, 24 – 32. https://doi.org/10.1016/j.addbeh.2018.06.013
dc.identifier.citedreferenceSchepis, T. S., Wastila, L., Ammerman, B., McCabe, V. V., & McCabe, S. E. ( 2020 ). Prescription opioid misuse motives in US older adults. Pain Medicine, 21 ( 10 ), 2237 – 2243. https://doi.org/10.1093/pm/pnz304
dc.identifier.citedreferenceSchepis, T. S., West, B. T., Teter, C. J., & McCabe, S. E. ( 2016 ). Prevalence and correlates of co‐ingestion of prescription tranquilizers and other psychoactive substances by U.S. high school seniors: Results from a national survey. Addictive Behaviors, 52, 8 – 12. https://doi.org/10.1016/j.addbeh.2015.08.002
dc.identifier.citedreferenceSchepis, T. S., Wilens, T. E., & McCabe, S. E. ( 2019 ). Prescription drug misuse: Sources of controlled medications in adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 58 ( 7 ), 670 – 680. https://doi.org/10.1016/j.jaac.2018.09.438
dc.identifier.citedreferenceSubstance Abuse and Mental Health Services Administration. ( 2019 ).  Results from the 2018 National Survey on Drug Use and Health: Detailed tables. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.
dc.identifier.citedreferenceUnited Nations Office on Drugs and Crime. ( 2019 ). World drug report 2019. (United Nations publication, Sales No. E.19.XI.8). United Nations Office on Drugs and Crime.
dc.identifier.citedreferenceVotaw, V. R., Geyer, R., Rieselbach, M. M., & McHugh, R. K. ( 2019 ). The epidemiology of benzodiazepine misuse: A systematic review. Drug and Alcohol Dependence, 200, 95 – 114. https://doi.org/10.1016/j.drugalcdep.2019.02.033
dc.identifier.citedreferenceWali, H., Hudani, Z., Wali, S., Mercer, K., & Grindrod, K. ( 2016 ). A systematic review of interventions to improve medication information for low health literate populations. Research in Social and Administrative Pharmacy, 12 ( 6 ), 830 – 864. https://doi.org/10.1016/j.sapharm.2015.12.001
dc.identifier.citedreferenceWall, M., Cheslack‐Postava, K., Hu, M. C., Feng, T., Griesler, P., & Kandel, D. B. ( 2018 ). Nonmedical prescription opioids and pathways of drug involvement in the US: Generational differences. Drug and Alcohol Dependence, 182, 103 – 111. https://doi.org/10.1016/j.drugalcdep.2017.10.013
dc.identifier.citedreferenceWu, L. T., & Blazer, D. G. ( 2011 ). Illicit and nonmedical drug use among older adults: A review. Journal of Aging and Health, 23 ( 3 ), 481 – 504. https://doi.org/10.1177/0898264310386224
dc.identifier.citedreferenceZanarini, M. C., & Frankenburg, F. R. ( 2001 ). Attainment and maintenance of reliability of axis I and II disorders over the course of a longitudinal study. Comprehensive Psychiatry, 42 ( 5 ), 369 – 374.
dc.identifier.citedreferenceFord, J. A., Hinojosa, M. S., & Nicholson, H. L. ( 2018 ). Disability status and prescription drug misuse among U.S. adults. Addictive Behaviors, 85, 64 – 69. https://doi.org/10.1016/j.addbeh.2018.05.019
dc.identifier.citedreferenceAmerican Psychiatric Association. ( 2000 ). Diagnostic and statistical manual of mental disorders: DSM‐IV‐TR ( 4th ed. ). American Psychiatric Association.
dc.identifier.citedreferenceAshrafioun, L., Heavey, S., Canarapen, T., Bishop, T. M., & Pigeon, W. R. ( 2019 ). The relationship between past 12‐month suicidality and reasons for prescription opioid misuse. Journal of Affective Disorders, 249, 45 – 51. https://doi.org/10.1016/j.jad.2019.02.008
dc.identifier.citedreferenceBaggio, S., Deline, S., Studer, J., N’Goran, A., Mohler‐Kuo, M., Daeppen, J. B., & Gmel, G. ( 2014 ). Concurrent versus simultaneous use of alcohol and non‐medical use of prescription drugs: Is simultaneous use worse for mental, social, and health issues? Journal of Psychoactive Drugs, 46 ( 4 ), 334 – 339. https://doi.org/10.1080/02791072.2014.921747
dc.identifier.citedreferenceBelzak, L., & Halverson, J. ( 2018 ). The opioid crisis in Canada: A national perspective. [La crise des opioïdes au Canada: Une perspective nationale]. Health Promotion and Chronic Disease Prevention in Canada, 38 ( 6 ), 224 – 233. https://doi.org/10.24095/hpcdp.38.6.02
dc.identifier.citedreferenceBlanco, C., Han, B., Jones, C. M., Johnson, K., & Compton, W. M. ( 2018 ). Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the United States. Journal of Clinical Psychiatry, 79 ( 6 ), 18m12174. https://doi.org/10.4088/JCP.18m12174
dc.identifier.citedreferenceBoeri, M. ( 2018 ). Hurt: Chronicles of the drug war generation. Oakland, California: University of California Press.
dc.identifier.citedreferenceCarmona, J., Maxwell, J. C., Park, J. Y., & Wu, L. T. ( 2020 ). Prevalence and health characteristics of prescription opioid use, misuse, and use disorders among U.S. adolescents. Journal of Adolescent Health, 66 ( 5 ), 536 – 544. https://doi.org/10.1016/j.jadohealth.2019.11.306
dc.identifier.citedreferenceCenter for Behavioral Health Statistics and Quality. ( 2014 ). National Survey on Drug Use and Health (NSDUH): Summary of methodological studies, 1971‐2014. Rockville, MD: Substance Abuse and Mental Health Services Administration.
dc.identifier.citedreferenceCenter for Behavioral Health Statistics and Quality. ( 2017a ). National Survey on Drug Use and Health: Methodological resource book (Section 8, data collection final report). Substance Abuse and Mental Health Services Administration.
dc.identifier.citedreferenceCenter for Behavioral Health Statistics and Quality. ( 2017b ). National Survey on Drug Use and Health: Methodological resource book (Section 13: Statistical inference report). Substance Abuse and Mental Health Services Administration.
dc.identifier.citedreferenceCompton, W. M., Han, B., Blanco, C., Johnson, K., & Jones, C. M. ( 2018 ). Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States. American Journal of Psychiatry, 175 ( 8 ), 741 – 755. https://doi.org/10.1176/appi.ajp.2018.17091048
dc.identifier.citedreferenceCunningham, D., Flicker, L., Murphy, J., Aldworth, J., Myers, S., & Kennet, J. ( 2015 ). Incidence and impact of controlled access situations on nonresponse. Paper presented at the American Association for Public Opinion Research 60th Annual Conference, Miami Beach, FL. https://www.rti.org/pubs/cunninghampaper.pdf
dc.identifier.citedreferenceDupont, R. L., Coleman, J. J., Bucher, R. H., & Wilford, B. B. ( 2008 ). Characteristics and motives of college students who engage in nonmedical use of methylphenidate. American Journal on Addictions, 17 ( 3 ), 167 – 171. https://doi.org/10.1080/10550490802019642
dc.identifier.citedreferenceEuropean Monitoring Centre for Drugs and Drug Addiction. ( 2019 ). Drug‐related deaths and mortality in Europe: Update from the EMCDDA expert network. Publications Office of the European Union.
dc.identifier.citedreferenceFischer, B., Cruz, M. F., & Rehm, J. ( 2006 ). Illicit opioid use and its key characteristics: A select overview and evidence from a Canadian multisite cohort of illicit opioid users (OPICAN). Canadian Journal of Psychiatry, 51 ( 10 ), 624 – 634. https://doi.org/10.1177/070674370605101002
dc.identifier.citedreferenceFord, J. A. ( 2019 ). Prescription opioid misuse among adolescents. Pediatric Clinics of North America, 66 ( 6 ), 1099 ‐ 1108. https://doi.org/10.1016/j.pcl.2019.08.005
dc.identifier.citedreferenceFox, L. M., Hoffman, R. S., Vlahov, D., & Manini, A. F. ( 2018 ). Risk factors for severe respiratory depression from prescription opioid overdose. Addiction, 113 ( 1 ), 59 – 66. https://doi.org/10.1111/add.13925
dc.identifier.citedreferenceGlei, D. A., Stokes, A., & Weinstein, M. ( 2020 ). Changes in mental health, pain, and drug misuse since the mid‐1990s: Is there a link? Social Science & Medicine, 246, 112789. https://doi.org/10.1016/j.socscimed.2020.112789
dc.identifier.citedreferenceGrant, B. F., Chu, A., Sigman, R., Amsbary, M., Kali, J., Sugawara, Y., & Goldstein, R. ( 2014 ). Source and accuracy statement: National Epidemiologic Survey on Alcohol and Related Conditions‐III (NESARC‐III). National Institute on Alcohol Abuse and Alcoholism.
dc.identifier.citedreferenceGrigsby, T. J., & Howard, J. T. ( 2019 ). Prescription opioid misuse and comorbid substance use: Past 30‐day prevalence, correlates and co‐occurring behavioral indicators in the 2016 National Survey on Drug Use and Health. American Journal on Addictions, 28 ( 2 ), 111 – 118. https://doi.org/10.1111/ajad.12866
dc.identifier.citedreferenceGrucza, R. A., Agrawal, A., Krauss, M. J., Bongu, J., Plunk, A. D., Cavazos‐Rehg, P. A., & Bierut, L. J. ( 2016 ). Declining prevalence of marijuana use disorders among adolescents in the United States, 2002 to 2013. Journal of the American Academy of Child & Adolescent Psychiatry, 55 ( 6 ), 487 – 494. https://doi.org/10.1016/j.jaac.2016.04.002
dc.identifier.citedreferenceHan, B., Compton, W. M., Blanco, C., Crane, E., Lee, J., & Jones, C. M. ( 2017 ). Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine, 167 ( 5 ), 293 – 301. https://doi.org/10.7326/m17‐0865
dc.identifier.citedreferenceHaukka, J., Kriikku, P., Mariottini, C., Partonen, T., & Ojanperä, I. ( 2018 ). Non‐medical use of psychoactive prescription drugs is associated with fatal poisoning. Addiction, 113 ( 3 ), 464 – 472. https://doi.org/10.1111/add.14014
dc.identifier.citedreferenceHumeniuk, R. E., Henry‐Edwards, S., Ali, R. L., Poznyak, V., & Monteiro, M. ( 2010a ). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): Manual for use in primary care. World Health Organization.
dc.identifier.citedreferenceHumeniuk, R. E., Henry‐Edwards, S., Ali, R. L., Poznyak, V., & Monteiro, M. ( 2010b ). The ASSIST‐linked brief intervention for hazardous and harmful substance use: Manual for use in primary care. World Health Organization.
dc.identifier.citedreferenceJohnston, L. D., & O’Malley, P. M. ( 1985 ). Issues of validity and population coverage in student surveys of drug use. NIDA Research Monograph, 57, 31 – 54.
dc.identifier.citedreferenceKessler, R. C., Barker, P. R., Colpe, L. J., Epstein, J. F., Gfroerer, J. C., Hiripi, E., Zaslavsky, A. M., Normand, S.‐L. T., Manderscheid, R. W., Walters, E. E., & Zaslavsky, A. M. ( 2003 ). Screening for serious mental illness in the general population. Archives of General Psychiatry, 60 ( 2 ), 184 – 189.
dc.identifier.citedreferenceKrist, A. H., Davidson, K. W., Mangione, C. M., Barry, M. J., Cabana, M., Caughey, A. B., Wong, J. B., Curry, S. J., Donahue, K., Doubeni, C. A., Epling, J. W., Kubik, M., Ogedegbe, G., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C.‐W., & Wong, J. B. ( 2020 ). Screening for unhealthy drug use: US Preventive Services Task Force Recommendation Statement. JAMA, 323 ( 22 ), 2301 – 2309. https://doi.org/10.1001/jama.2020.8020
dc.identifier.citedreferenceMaree, R. D., Marcum, Z. A., Saghafi, E., Weiner, D. K., & Karp, J. F. ( 2016 ). A systematic review of opioid and benzodiazepine misuse in older adults. American Journal of Geriatric Psychiatry, 24 ( 11 ), 949 – 963. https://doi.org/10.1016/j.jagp.2016.06.003
dc.identifier.citedreferenceMartins, S. S., Fenton, M. C., Keyes, K. M., Blanco, C., Zhu, H., & Storr, C. L. ( 2012 ). Mood and anxiety disorders and their association with non‐medical prescription opioid use and prescription opioid‐use disorder: Longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychological Medicine, 42 ( 6 ), 1261 – 1272. https://doi.org/10.1017/S0033291711002145
dc.identifier.citedreferenceMcCabe, S. E., Boyd, C. J., & Teter, C. J. ( 2009 ). Subtypes of nonmedical prescription drug misuse. Drug and Alcohol Dependence, 102 ( 1–3 ), 63 – 70. https://doi.org/10.1016/j.drugalcdep.2009.01.007
dc.identifier.citedreferenceMcCabe, S. E., Cranford, J. A., Morales, M., & Young, A. ( 2006 ). Simultaneous and concurrent polydrug use of alcohol and prescription drugs: Prevalence, correlates, and consequences. Journal of Studies on Alcohol, 67 ( 4 ), 529 – 537.
dc.identifier.citedreferenceMcCabe, S. E., Veliz, P., & Patrick, M. E. ( 2017 ). High‐intensity drinking and nonmedical use of prescription drugs: Results from a national survey of 12th grade students. Drug and Alcohol Dependence, 178, 372 – 379. https://doi.org/10.1016/j.drugalcdep.2017.05.038
dc.identifier.citedreferenceMcCabe, S. E., West, B. T., Schepis, T. S., & Teter, C. J. ( 2015 ). Simultaneous co‐ingestion of prescription stimulants, alcohol and other drugs: A multi‐cohort national study of US adolescents. Human Psychopharmacology, 30 ( 1 ), 42 – 51. https://doi.org/10.1002/hup.2449
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hup2803.pdf
Size:
276.1KB
Format:
PDF
View/Open
Name:
hup2803_am.pdf
Size:
1.107MB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.